Source: Υπουργείο Υγείας (CY) Revision Year: 2015 Publisher: Medochemie, Ltd, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
Medoclazide 80 mg tablets.
| Pharmaceutical Form |
|---|
|
Tablet. White, round, flat, scored, with 8mm diameter. |
Each tablet contains 80mg of gliclazide.
Excipient with known effect: lactose monohydrate. Each 80mg tablet contains 80mg lactose monohydrate.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Gliclazide |
Gliclazide is a hypoglycaemic sulfonylurea antidiabetic active substance. Gliclazide reduces blood glucose levels by stimulating insulin secretion from the β-cells of the islets of Langerhans. |
| List of Excipients |
|---|
|
The tablets also contain microcrystalline cellulose, lactose spray dried, croscarmellose sodium, colloidal silicon dioxide, talc, and magnesium stearate. |
Blisters of aluminium foil and polyvinylchloride film containing ten tablets. Blisters are supplied, with a patient information leaflet, in cartons of 20, 60 and 100 tablets. Dispensing packs of 500 and 1000 tablets are also available, either packed in blisters in a carton or in polyvinylchloride securitainers. Note that not all packaging presentations may be available in the market.
Medochemie, Ltd, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
9819
18.02.1985 / 07.06.2012
| Drug | Countries | |
|---|---|---|
| MEDOCLAZIDE | Cyprus, Malta, Singapore |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
